CTX-M-producing non-Typhi Salmonella Spp. Isolated from humans, United States

Emerging Infectious Diseases

Volumn 17, Issue 1, 2011, Pages 97-99

  Sjölund Karlsson, Maria ^a,b   Howie, Rebecca ^b   Krueger, Amy ^b   Rickert, Regan ^b   Pecic, Gary ^b   Lupoli, Kathryn ^b   Folster, Jason P ^b   Whichard, Jean M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE CTX M; CEFTIOFUR; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; NALIDIXIC ACID; STREPTOMYCIN; SULFAFURAZOLE; SULFAMETHOXAZOLE; TETRACYCLINE;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; FEMALE; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRESCHOOL CHILD; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; UNITED STATES;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFTRIAXONE; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; SALMONELLA; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SEROTYPING; UNITED STATES;

EID: 78650969879     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1701.100511     Document Type: Article

References (15)

1. Lewis JS II, Herrera M, Wickes B, Patterson JE, Jorgensen JH. First report of the emergence of CTX-M-type extended-spectrum betalactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother. 2007;51:4015-4021. DOI: 10.1128/AAC.00576-07
2. McGettigan SE, Hu B, Andreacchio K, Nachamkin I, Edelstein PH. Prevalence of CTX-M beta-lactamases in Philadelphia. J Clin Microbiol. 2009;47:2970-2974. DOI: 10.1128/JCM.00319-09
3. Castanheira M, Mendes RE, Rhomberg PR, Jones RN. Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. medical centers: molecular evaluation from the MYSTIC Program (2007). Microb Drug Resist. 2008;14:211-216. DOI: 10.1089/mdr.2008.0827
4. Bonnet R, Recule C, Baraduc R, Chanal C, Sirot D, De Champs C, et al. Effect of D240G substitution in a novel ESBL CTX-M-27. J Antimicrob Chemother. 2003;52:29-35. DOI: 10.1093/jac/dkg256
5. Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol. 2004;42:5715-5721. DOI: 10.1128/JCM.42.12.5715-5721.2004
6. Briñas L, Zarazaga M, Sáenz Y, Ruiz-Larrea F, Torres C. Betalactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob Agents Chemother. 2002;46:3156-3163. DOI: 10.1128/AAC.46.10.3156-3163.2002
7. Chen S, Zhao S, White DG, Schroeder CM, Lu R, Yang H, et al. Characterization of multiple-antimicrobial-resistant salmonella serovars isolated from retail meats. Appl Environ Microbiol. 2004;70:1-7. DOI: 10.1128/AEM.70.1.1-7.2004
8. Rasheed JK, Jay C, Metchock B, Berkowitz F, Weigel L, Crellin J, et al. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother. 1997;41:647-653.
9. Winokur PL, Vonstein DL, Hoffman LJ, Uhlenhopp EK, Doern GV. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob Agents Chemother. 2001;45:2716-2722. DOI: 10.1128/AAC.45.10.2716-2722.2001
10. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, et al. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother. 2004;48:1249-1255. DOI: 10.1128/AAC.48.4.1249-1255.2004
11. Sjölund M, Yam J, Schwenk J, Joyce K, Medalla F, Barzilay E, et al. Human Salmonella infection yielding CTX-M beta-lactamase, United States. Emerg Infect Dis. 2008;14:1957-1959. DOI: 10.3201/eid1412.080494
12. Huang S, Rickert R, Matar C, Pecic G, Howie RL, Joyce K, et al. Salmonella isolates with decreased susceptibility to extended-spectrum cephalosporins in the United States. Foodborne Pathog Dis. 2005;2:12-23. DOI: 10.1089/fpd.2005.2.12
13. Fabre L, Delaune A, Espie E, Nygard K, Pardos M, Polomack L, et al. Chromosomal integration of the extended-spectrum betalactamase gene blaCTX-M-15 in Salmonella enterica serotype Concord isolates from internationally adopted children. Antimicrob Agents Chemother. 2009;53:1808-1816. DOI: 10.1128/AAC.00451-08
14. Morosini MI, Valverde A, Garcia-Castillo M, Nordmann P, Canton R. Persistent isolation of Salmonella Concord harbouring CTX-M- 15, SHV-12 and QnrA1 in an asymptomatic adopted Ethiopian child in Spain also colonized with CTX-M-14- and QnrB-producing Enterobacteriaceae. J Antimicrob Chemother. 2010;65:1545-1546. DOI:10.1093/jac/dkq168
15. Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol. 2001;39:2206-2212. DOI:10.1128/JCM.39.6.2206-2212.2001